Hepatocellular carcinoma (HCC) is the most common primary liver cancer and has been
acknowledged as a leading cause of death among cirrhosis patients. Difficulties in early …

The focus of hepatocellular carcinoma (HCC) research for many years has been on
noninvasive diagnosis. Standardized systematic algorithms composed of combinations of …

Background Macrotrabecular-massive (MTM) subtype of hepatocellular carcinoma (HCC) is
an aggressive variant associated with angiogenesis and immunosuppressive tumor …

Background Macrotrabecular-massive (MTM) subtype and vessels encapsulating tumor
clusters (VETC) pattern of hepatocellular carcinoma (HCC) are associated with unfavorable …

Background Hepatocellular carcinomas (HCCs) are heterogeneous neoplasms, and the
prognosis varies based on the subtype. Two broad molecular classes of HCC have been …

Hepatocellular carcinoma (HCC) is a malignancy with variable biologic aggressiveness
based on the tumor grade, presence or absence of vascular invasion, and pathologic and …

Background Vessels encapsulating tumor cluster (VETC) is a critical prognostic factor and
therapeutic predictor of hepatocellular carcinoma (HCC). However, noninvasive evaluation …

Background It is unknown whether the additional information provided by multiparametric
dual-energy CT (DECT) could improve the noninvasive diagnosis of the aggressive …

Purpose In this study, we aimed to develop a novel liver function and inflammatory markers-
based nomogram to predict recurrence-free survival (RFS) for AFP-negative (< 20 ng/mL) …

Background Imaging markers of hepatocellular carcinoma (HCC) on the basis of molecular
classification are important for predicting malignancy grade and prognosis. P53-mutated …